Targeted therapies in ameloblastomas and ameloblastic carcinoma—A systematic review
Ronell Bologna‐Molina(Universidad de la República de Uruguay), Keith D. Hunter(University of Pretoria), Willie F. P. van Heerden(University of Pretoria), Elizabeth Ann Bilodeau(University of Pittsburgh), Wanninayake Mudiyanselage Tilakaratne(Niigata University), Liam Robinson(University of Pretoria), Ricardo Santiago Gomez(Universidade Federal de Minas Gerais), Kelly R. Magliocca(Emory University), Haizal Mohd Hussaini(University of Otago), Merva Soluk Tekkeşin(Istanbul University), Jiang Li(Shanghai Jiao Tong University), Akinyele Olumuyiwa Adisa(University of Ibadan), Lauren Frenzel Schuch(Universidad de la República de Uruguay)
Cited by 20
Related Papers
Oral submucous fibrosis: Review on aetiology and pathogenesis
|Oral Oncology|2005|658
The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer
|Molecular Cell|2017|345
Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
|Oncogene|2017|317
Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial
|Annals of Surgical Oncology|2010|259
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253